Home LiteratureArticle Details
PMID: 1847464 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.

Journal of virology ·Vol. 65 ·No. 3 ·1991-03-00 ·Pages 1466-78

Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD

Abstract

The Epstein-Barr virus (EBV)-encoded latency product EBNA-1 is functionally pleiotropic, being required for replication of the episomal form of the EBV genome and having a role in the regulation of latency transcription. EBNA-1 is a direct DNA-binding protein, and both replication and transactivation are dependent on the interaction of EBNA-1 with its cognate DNA recognition sequences. To better understand EBNA-1 function, we have further characterized the DNA-binding domain of EBNA-1 and have examined the contributions of other domains of the protein to EBNA-1 transactivation activity. A Bal31 deletional analysis of the carboxy-terminal region of EBNA-1 identified a core DNA-binding domain located between amino acids 493 and 584. Column chromatographic, sedimentation, and cross-linking studies indicated that EBNA-1 exists in solution as a dimer. Mobility retardation assays using in vitro-translated variants of EBNA-1 showed that the active DNA-binding form of EBNA-1 is also a dimer. In short-term cotransfections, a pFRTK-CAT target containing EBNA-1-binding sites from the EBV origin of plasmid replication, ori-P, was transactivated by a carboxy-terminal EBNA-1 construction (amino acids 450 to 641) that also carried a c-myc nuclear localization signal. These reconstruction experiments demonstrated that a transactivation domain exists within the carboxy-terminal region of EBNA-1, that transactivation is more efficient when a nuclear localization signal is present, and that the natural karyophilic signal lies outside of the carboxy-terminal 191 amino acids. To identify the EBNA-1 nuclear localization signal, small oligonucleotides representing EBNA-1 sequences that encode clusters of basic peptides were transferred into two different vectors expressing cytoplasmic proteins (pyruvate kinase and herpes simplex virus delta IE175 protein) and the cellular locations of the fusion constructions were determined by immunofluorescence staining of transfected cells. In this way we identified a functional nuclear localization signal, Leu-Lys-Arg-Pro-Arg-Ser-Pro-Ser-Ser, encompassing amino acids 379 to 386 of the EBNA-1 protein.

MeSH Terms
Amino Acid Sequence Animals Antigens, Viral/genetics,isolation & purification Base Sequence Cell Line Chromosome Deletion DNA-Binding Proteins/genetics Epstein-Barr Virus Nuclear Antigens Genes, Viral Herpesvirus 4, Human/genetics,immunology Macromolecular Substances Molecular Sequence Data Oligonucleotide Probes Plasmids Recombinant Fusion Proteins/isolation & purification Restriction Mapping Transcriptional Activation Transfection Vero Cells
Chemicals
Antigens, Viral DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens Macromolecular Substances Oligonucleotide Probes Recombinant Fusion Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ambinder R F
Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland 21205.
Mullen M A
Chang Y N
Hayward G S
Hayward S D
References (39)
39 references, click to expand
  1. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
    J Virol. 1990 Jul;64(7):3358-69 PMID: 2161945
  2. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.
    Science. 1988 Jun 24;240(4860):1759-64 PMID: 3289117
  3. Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.
    Proc Natl Acad Sci U S A. 1982 Sep;79(18):5688-92 PMID: 6291059
  4. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
    Proc Natl Acad Sci U S A. 1984 Jun;81(12):3806-10 PMID: 6328526
  5. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Cell. 1989 Aug 11;58(3):527-35 PMID: 2547525
  6. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.
    J Virol. 1989 Jul;63(7):3016-25 PMID: 2542609
  7. Recognition of a DNA operator by the repressor of phage 434: a view at high resolution.
    Science. 1988 Nov 11;242(4880):899-907 PMID: 3187531
  8. Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA.
    Science. 1984 Dec 14;226(4680):1322-5 PMID: 6095452
  9. pBD7, a novel cell-free expression vector with efficient translation initiation signal.
    Nucleic Acids Res. 1987 May 11;15(9):3933 PMID: 3675735
  10. GCN4, a eukaryotic transcriptional activator protein, binds as a dimer to target DNA.
    EMBO J. 1987 Sep;6(9):2781-4 PMID: 3678204
  11. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.
    Infect Immun. 1981 Dec;34(3):684-92 PMID: 6277788
  12. Protein-DNA recognition.
    Annu Rev Biochem. 1984;53:293-321 PMID: 6236744
  13. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.
    J Mol Biol. 1976 Apr 15;102(3):511-30 PMID: 178878
  14. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins.
    J Biol Chem. 1989 Oct 25;264(30):18019-23 PMID: 2553699
  15. Structure of the lambda complex at 2.5 A resolution: details of the repressor-operator interactions.
    Science. 1988 Nov 11;242(4880):893-9 PMID: 3187530
  16. Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus.
    Nature. 1988 Sep 29;335(6189):452-4 PMID: 2843776
  17. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    J Virol. 1989 Jun;63(6):2657-66 PMID: 2542579
  18. High-efficiency transformation of mammalian cells by plasmid DNA.
    Mol Cell Biol. 1987 Aug;7(8):2745-52 PMID: 3670292
  19. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Mol Cell Biol. 1986 Nov;6(11):3838-46 PMID: 3025615
  20. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line.
    Cell. 1988 Jan 15;52(1):51-61 PMID: 2830981
  21. Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters.
    J Virol. 1985 Mar;53(3):751-60 PMID: 2983086
  22. High-resolution footprints of the DNA-binding domain of Epstein-Barr virus nuclear antigen 1.
    Mol Cell Biol. 1989 Jun;9(6):2738-42 PMID: 2548088
  23. Epstein-Barr virus nuclear antigen forms a complex that binds with high concentration dependence to a single DNA-binding site.
    J Virol. 1987 Feb;61(2):465-71 PMID: 3027376
  24. Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).
    Nucleic Acids Res. 1988 Apr 25;16(8):3415-35 PMID: 2836795
  25. Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons.
    Proc Natl Acad Sci U S A. 1985 Dec;82(24):8305-9 PMID: 3001694
  26. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
    Mol Cell Biol. 1985 Oct;5(10):2533-42 PMID: 3016506
  27. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5096-100 PMID: 3460083
  28. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.
    J Virol. 1989 Jun;63(6):2644-9 PMID: 2542577
  29. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.
    J Virol. 1989 Jan;63(1):101-10 PMID: 2535719
  30. The nuclear location signal.
    Proc R Soc Lond B Biol Sci. 1985 Oct 22;226(1242):43-58 PMID: 2866523
  31. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.
    Cell. 1985 Oct;42(3):859-68 PMID: 2996781
  32. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Proc Natl Acad Sci U S A. 1985 Sep;82(18):6300-4 PMID: 2412231
  33. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  34. The effect of protein context on nuclear location signal function.
    Cell. 1987 Jul 31;50(3):465-75 PMID: 3038333
  35. Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus.
    J Virol. 1987 May;61(5):1559-70 PMID: 3033283
  36. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
    Mol Cell Biol. 1985 Feb;5(2):410-3 PMID: 2983194
  37. Mutants of GAL4 protein altered in an activation function.
    Cell. 1987 Oct 9;51(1):121-6 PMID: 3115592
  38. How eukaryotic transcriptional activators work.
    Nature. 1988 Oct 20;335(6192):683-9 PMID: 3050531
  39. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA.
    J Virol. 1990 May;64(5):2369-79 PMID: 2157891
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1991-03-00
Pages
1466-78
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC239927
Subset
IM
Grants
NIAID NIH HHS · K11 AI00648 · United States
NCI NIH HHS · R01CA28473 · United States
NCI NIH HHS · R01CA42245 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com